BodyNovaWellness

← All peptides

BPC-157 + TB-500 — Research use only
BodyNovaWellness

BPC-157 + TB-500

20 MG(BPC-157 + TB-500)
Research use only

Not for human consumption
STORE REFRIGERATED 2–8 °C (36–46 °F)
Recovery & Healing
Research use only

BPC-157 + TB-500

A BPC-157 and TB-500 pairing studied in tissue-repair and recovery research.

$65 USD per vial

Also known as: BPC-157 + TB-500, Wolverine Blend, Body Protection Compound 157 + Thymosin beta-4 fragment

Composition
BPC-157TB-500

Overview

This blend pairs BPC-157 with TB-500, two peptides frequently studied together as a tissue-recovery combination. BPC-157 is a synthetic 15-amino-acid pentadecapeptide derived from a protective protein found in gastric juice; its research is mostly preclinical, drawn from animal and laboratory models of tendon and ligament recovery, muscle and tissue repair, inflammation, wound healing, and recovery from exercise-related injury, with no adequate controlled human trials to date. TB-500 is a synthetic fragment related to thymosin beta-4, corresponding to its actin-binding domain, and is studied mainly in laboratory and animal models of wound healing, tissue repair, muscle recovery, tendon and ligament recovery, and the processes involved in blood-vessel formation (angiogenesis) and tissue remodeling; its human clinical evidence is very limited. Together the two are commonly examined as a tissue-recovery pairing for muscle, tendon, and ligament models, and the available evidence remains preclinical. It is offered here for research use only.

Research highlights

  • Pairs two peptides commonly studied together for tissue recovery
  • BPC-157 is a synthetic 15-amino-acid pentadecapeptide derived from a protein found in gastric juice
  • TB-500 is a synthetic fragment related to thymosin beta-4, corresponding to its actin-binding domain
  • Studied in models of tendon, ligament, and muscle recovery
  • Investigated in models of tissue repair, inflammation, and wound healing
  • TB-500 explored in angiogenesis and tissue-remodeling research, with evidence that remains preclinical

Related peptides